Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassador
    • Our impact
    • Annual reports
    • Contact us
  • ME/CFS information
    • What is ME/CFS?
    • Diagnosis
    • Treatment and management
    • What is fibromyalgia?
    • ME/CFS - what's in a name?
    • For health professionals
    • Member stories
  • Research
    • OMF Australia
    • ME/CFS biobank and registry
    • ANCHOR Study
    • Research Digest
    • Health and Wellbeing Survey
  • How to get help
    • InfoLine
    • Telehealth Nurse Service
    • Peer support groups
    • Accessing financial support
      • About NDIS
      • About DSP
      • Financial literacy resources for ME/CFS
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Bequest giving
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Day
  • Shop
  • News
    • News
  • Admin
    • Log in
  • Basket: (0 items)

Treatment and management

Currently, there is no cure for ME/CFS or evidence-based treatments that are proven to be effective. However, there is still a lot that health professionals can do for people living with ME/CFS. The goal of treatment is to improve a patient's quality of life and to provide relief from symptoms.

Current treatment for ME/CFS has three key aspects:

  • pacing
  • rest
  • stepwise symptom management

Pacing and rest

Pacing is a management strategy designed to help people with ME/CFS live within their energy envelope and minimise post-exertional malaise (PEM). The energy envelope is the amount of energy a person with ME/CFS has available each day. This is energy that they can safely use without triggering post-exertional malaise (which is the worsening of symptoms after exertion).

Pacing can help patients to improve their quality of life and reduce their symptoms although it is not a cure. Pacing is considered to be an important self-management tool by doctors who specialise in treating people with ME/CFS and by patients around the world.Pacing involves undertaking less activity than the patient has energy available for on a given day, and breaking activities down into short bursts, interspersed with rest. For example, instead of taking a shower, brushing their teeth and combing their hair in one go, pacing might mean that they take a shower and then rest, until they feel ready to undertake the next activity.

The aim of pacing is to leave some ‘fuel in the tank’ at the end of the activity. Some ME/CFS doctors advise their patients to try to do no more than 50-60% of what they feel they can do. Pacing, like any other skill, must be practised. It becomes easier over time.

Rest should mean absolutely minimal activity, which means no stimulation. TV, social media, reading or listening to music can all be stimulating - doing these activities stops the body resting fully. Good pacing involves including periods of rest throughout the day and especially between activities. If possible, patients should not attempt more activity until their PEM has reduced.

You can download a fact sheet on pacing here.  

Be realistic

In an ideal world, patients would always be able to stay within their energy envelope and would never experience PEM but this is probably not possible or realistic. Many people have work or family commitments, or live alone, and daily life takes them beyond their energy envelope.

In addition to this, sometimes there are activities that they want to do and that are important for overall wellbeing that will take them outside of their energy envelope. It is important to be flexible and realistic, but also to return to the principles of pacing and try to build them into everyday life. 

Stepwise symptom management

While pacing and rest are self-management approaches, GPs and healthcare practitioners can help with stepwise symptom management.

This involves:

  • ranking symptoms from most to least problematic
  • exploring options to help reduce symptoms, starting with the most problematic 

This approach to management isn’t treating the underlying cause of ME/CFS, but it can help to improve overall quality of life. In undertaking this approach, GPs should also take into account that many people with ME/CFS are sensitive to medications, so they should take a ‘start-low, go-slow’ approach.

Published: 16th April, 2019

Updated: 22nd January, 2020

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Help us give the gift of knowledge this Christmas

    Help us give the gift of knowledge this Christmas

    People with ME/CFS face multiple challenges every day. Despite the devastating impact of this illness, thousands of Australians living with ME/CFS struggle to access high-quality, knowledgeable help.

  • Research Digest 11/12/20

    Research Digest 11/12/20

    Welcome to the 61st edition of the Research Digest. This fortnight's edition features a study investigating microRNA expression differences in ME/CFS patients before and after experiencing PEM, and a study that aimed to develop a sensor-based method to track upright activity as a way to measure ME/CFS disease severity.

  • Research Digest 27/11/20

    Research Digest 27/11/20

    Welcome to the 60th edition of the Research Digest featuring a study that aimed to determine whether there are differences in cardiac function in ME/CFS patients and a plasma proteomic analysis study.

  • New ME/CFS Clinical Guidelines for the UK

    New ME/CFS Clinical Guidelines for the UK

    The UK’s National Institute for Health and Care Excellence has published its long-awaited draft of the new ME/CFS clinical guidelines.

Most read

  • Open Medicine Foundation Australia

    Open Medicine Foundation Australia

    Emerge Australia is proud to be launching the 5th addition to a global network of OMF-established Collaborative Research Centres, with our partner, Open Medicine Foundation, seeing an Australian centre join with those at Harvard, Stanford, Uppsala, and Montreal universities.

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • Australian Research Centre to Open Early in 2021

    Australian Research Centre to Open Early in 2021

    The new Australian ME/CFS Centre for Collaborative Research is expected to officially open early in 2021

  • Research Digest 30/10/20

    Welcome to the 58th edition of the Research Digest featuring a focus group study that aimed to gain insight into the PEM experiences of ME/CFS patients and a cluster analysis study defining subgroups of patients based on several measures of autonomic dysfunction.

  • Research Digest 04/09/20

    Welcome to the 54th edition of the Research Digest. This fortnight's edition includes summary of a functional MRI study exploring brain responses to autonomic challenges in ME/CFS patients with and without temporomandibular disorder.

  • Research Digest 13/11/20

    Research Digest 13/11/20

    Welcome to the 59th edition of the Research Digest. This issue features a review article on the eitology of ME/CFS and a systematic review of neuroimaging studies.

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.

  • Research Digest 16/10/20

    Welcome to the 57th edition of the Research Digest featuring the results of the NHMRC ME/CFS Targeted Call for Research funding and a study that aimed to compare the subjective severity scoring of the SF-36 (based on the physical activity subscale) to two objective measures of activity in order to validate the way in which clinical severity is graded in ME/CFS.

  • What is fibromyalgia?

    Fibromyalgia is an associated condition of ME/CFS

  • Accessibility

Join our community

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Ross House
247 - 251 Flinders Lane
Melbourne VIC 3000
1800 865 321
03 9529 1344
 

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.